Preclinical CRO Market 2030: The Growing Demand for Complex Research

Preclinical CRO Market Growth & Trends

The global preclinical CRO market size is expected to reach USD 10.26 billion by 2030, registering a CAGR of 8.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is expected to show lucrative growth due to increasing R&D expenditure and rising outsourcing trends. The increasing volume of new drugs entering the preclinical phase is also anticipated to boost the market during the forecast period. However, the COVID-19 pandemic had temporarily affected the market owing to the shutdown of research sites due to the implementation of national lockdowns.

Gather more insights about the market drivers, restrains and growth of the Global Preclinical CRO market

The market is undergoing a series of mergers and acquisitions, resulting in improvement in full-service capabilities and the international reach of larger companies. For instance, in 2019, WuXi AppTec acquired Pharmapace. On the other hand, mid-sized and smaller contract research organizations are focusing on niche sectors and are providing a personalized approach to their sponsors. Various companies are focusing on research and development of new drugs and therefore are outsourcing these activities to launch efficient CRO services in the market. This, in turn, provides a positive atmosphere for joint ventures among market participants owing to the preference of sponsors to maximize their benefits.

The COVID-19 pandemic is ever increasing since the disease was first identified in China in December 2019. Until March 9, 2022, more than 4500 million cases of COVID-19 were reported globally; this pandemic has fast-tracked the development of vaccines and drug testing. There are currently over 195 COVID-19 vaccine candidates in preclinical studies.

Preclinical CRO Market Report Highlights

• The toxicology testing segment accounted for the largest share of more than 25.4% in 2023 due to its significance in Investigational New Drug (IND)-enabling studies
• The Patient Derived Organoid (PDO) Model segment held the largest share of 80.6% in 2023, owing to the high accuracy obtained by this model
• The government and academic institutes segment is anticipated to witness the fastest CAGR of 9.1% during the forecast period. This growth is credited to the rising government initiatives in the healthcare sector, especially in developing economies
• North America held the highest revenue share of the global market in 2023. Huge investments in healthcare R&D, coupled with well-developed healthcare infrastructure in the U.S., contributed to the market growth in North America. Asia Pacific is projected to expand with the fastest CAGR of 11.6% during the forecast period.

Browse through Grand View Research’s Medical Devices Industry Research Reports.

• Semi-Solid Dosage CDMO Market Size, Share & Trends Analysis Report By Route of Administration (Topical, Transdermal, Others), By Product, By Service, By End Use, By Country, And Segment Forecasts, 2024 – 2030
• Medical Equipment Calibration Services Market Size, Share & Trend Analysis Report By Service (OEM, Third-party Services), By End Use (Hospitals, Clinical Laboratories), By Region, And Segment Forecasts, 2024 – 2030

Preclinical CRO Market Segmentation

Grand View Research has segmented the global preclinical CRO market based on service, model type, end-use, and region:

Preclinical CRO Service Outlook (Revenue, USD Billion, 2018 – 2030)

• Bioanalysis and DMPK studies
  • In vitro ADME
  • In-vivo PK
• Toxicology Testing
  • GLP
  • Non-GLP
• Compound Management
  • Process R&D
  • Custom Synthesis
  • Others
• Chemistry
  • Medicinal Chemistry
  • Computation Chemistry
• Safety Pharmacology
• Others

Preclinical CRO Model Type Outlook (Revenue, USD Billion, 2018 – 2030)

• Patient Derived Organoid (PDO) Model
• Patient derived xenograft model

Preclinical CRO End-use Outlook (Revenue, USD Billion, 2018 – 2030)

• Biopharmaceutical Companies
• Government and Academic Institutes
• Medical Device Companies

Preclinical CRO Regional Outlook (Revenue, USD Billion, 2018 – 2030)

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Sweden
  • Norway
  • Denmark
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Order a free sample PDF of the Preclinical CRO Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research is a full-time market research and consulting company registered in San Francisco, California. The company fully offers market reports, both customized and syndicates, based on intense data analysis. It also offers consulting services to business communities and academic institutions and helps them understand the global and business scenario to a significant extent. The company operates across multitude of domains such as Chemicals, Materials, Food and Beverages, Consumer Goods, Healthcare, and Information Technology to offer consulting services.

Explore Horizon, the world’s most expansive market research database